Ann Lee, Ph.D.

Ann Lee, Ph.D.

DirectoratPrime Medicine· In proxies 2022–2025

Pay in FY2025Prime Medicine stock +18.8% the same year

Ann Lee, Ph.D. was paid $1.6M in FY2025 (Dec). Prime Medicine stock rose 18.8% that year.

Pay$100 in the stock at the end of FY22 → $57
Pay is from the Summary Compensation Table of each Prime Medicine proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Coya TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  2. Prime MedicinePublic company · 4 yr
    • 2022 – Present · 4 yrStock in role -65%
  3. JWPublic company
    • Director? – PresentNo stock prices for these years
  4. Therapeutics Co.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?